Pages that link to "Q67960261"
Jump to navigation
Jump to search
The following pages link to Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease (Q67960261):
Displaying 50 items.
- FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Aβ (Q22242369) (← links)
- The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein (Q24336853) (← links)
- The apolipoprotein E gene, attention, and brain function (Q24539024) (← links)
- Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein (Q24563093) (← links)
- Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease (Q24670696) (← links)
- Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease (Q26783325) (← links)
- Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders (Q26850298) (← links)
- The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease (Q26991654) (← links)
- Neuronal death induced by misfolded prion protein is due to NAD depletion and can be relieved in vitro and in vivo by NAD replenishment (Q27303843) (← links)
- Cognitive and social lifestyle: links with neuropathology and cognition in late life (Q28304421) (← links)
- Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease (Q28542628) (← links)
- Nonhuman primate models of Alzheimer-like cerebral proteopathy (Q28728135) (← links)
- The oldest old and the 90 Study (Q28728600) (← links)
- Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease. (Q30361851) (← links)
- Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions (Q30478907) (← links)
- The concentration of soluble extracellular amyloid-β protein in acute brain slices from CRND8 mice (Q30994762) (← links)
- Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients (Q33305771) (← links)
- Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers (Q33456273) (← links)
- Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease (Q33603749) (← links)
- Multimodal techniques for diagnosis and prognosis of Alzheimer's disease (Q33607535) (← links)
- Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease (Q33614523) (← links)
- Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients (Q33633043) (← links)
- Elevated Aβ42 in aged, non-demented individuals with cerebral atherosclerosis (Q33697128) (← links)
- Molecular polymorphism of Abeta in Alzheimer's disease (Q33741493) (← links)
- Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes (Q33772805) (← links)
- Neuropathologic assessment of dementia markers in identical and fraternal twins (Q33784747) (← links)
- An expanded role for neuroimaging in the evaluation of memory impairment (Q33830698) (← links)
- Contribution of cognitive performance and cognitive decline to associations between socioeconomic factors and dementia: A cohort study (Q33834863) (← links)
- Clinico-pathological correlation in dementias (Q33921583) (← links)
- PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease (Q33936595) (← links)
- Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept (Q34004313) (← links)
- Cognition, glucose metabolism and amyloid burden in Alzheimer's disease (Q34061233) (← links)
- Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA) (Q34298372) (← links)
- The importance of cognitive aging for understanding dementia (Q34306400) (← links)
- Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression (Q34461748) (← links)
- Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease (Q34509732) (← links)
- Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease (Q34518915) (← links)
- National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (Q34635272) (← links)
- The diarylheptanoid ( )-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. (Q34761869) (← links)
- Role of the neuropathology of Alzheimer disease in dementia in the oldest-old (Q34764490) (← links)
- Is there a neuropathology difference between mild cognitive impairment and dementia? (Q34776816) (← links)
- Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults (Q34922621) (← links)
- Diagnostic thresholds with three ordinal groups (Q35016828) (← links)
- Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease (Q35019429) (← links)
- Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. (Q35019451) (← links)
- Cognitive reserve in aging. (Q35103247) (← links)
- Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD. (Q35112517) (← links)
- Confidence interval estimation of the difference between two sensitivities to the early disease stage (Q35146119) (← links)
- Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss (Q35152147) (← links)
- Does cognitive reserve shape cognitive decline? (Q35154095) (← links)